nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—VEGFA—Carvedilol—hypertension	0.0829	0.318	CbGbCtD
Vandetanib—PDGFRB—hypertension	0.0814	0.214	CbGaD
Vandetanib—SRC—hypertension	0.0656	0.173	CbGaD
Vandetanib—KDR—hypertension	0.0617	0.162	CbGaD
Vandetanib—ABCC1—hypertension	0.0611	0.161	CbGaD
Vandetanib—VEGFA—hypertension	0.0523	0.137	CbGaD
Vandetanib—EGFR—hypertension	0.0441	0.116	CbGaD
Vandetanib—ORM1—Penbutolol—hypertension	0.0189	0.0725	CbGbCtD
Vandetanib—ORM1—Doxazosin—hypertension	0.0182	0.0698	CbGbCtD
Vandetanib—ORM1—Prazosin—hypertension	0.0149	0.0573	CbGbCtD
Vandetanib—ALB—hypertension	0.0141	0.037	CbGaD
Vandetanib—ORM1—Propranolol—hypertension	0.0118	0.0455	CbGbCtD
Vandetanib—ALB—Ethacrynic acid—hypertension	0.0105	0.0402	CbGbCtD
Vandetanib—ABCG2—Telmisartan—hypertension	0.0101	0.0387	CbGbCtD
Vandetanib—ABCC1—Atorvastatin—hypertension	0.00919	0.0353	CbGbCtD
Vandetanib—ABCG2—Prazosin—hypertension	0.0091	0.035	CbGbCtD
Vandetanib—ABCC1—Verapamil—hypertension	0.00742	0.0285	CbGbCtD
Vandetanib—ALB—Valsartan—hypertension	0.00675	0.0259	CbGbCtD
Vandetanib—ABCG2—Verapamil—hypertension	0.00496	0.0191	CbGbCtD
Vandetanib—ALB—Captopril—hypertension	0.00492	0.0189	CbGbCtD
Vandetanib—CYP3A4—Guanethidine—hypertension	0.00474	0.0182	CbGbCtD
Vandetanib—ALB—Furosemide—hypertension	0.00396	0.0152	CbGbCtD
Vandetanib—ALB—Losartan—hypertension	0.00388	0.0149	CbGbCtD
Vandetanib—CYP3A4—Hydralazine—hypertension	0.00359	0.0138	CbGbCtD
Vandetanib—CYP3A4—Guanfacine—hypertension	0.00305	0.0117	CbGbCtD
Vandetanib—CYP3A4—Isradipine—hypertension	0.00272	0.0104	CbGbCtD
Vandetanib—CYP3A4—Indapamide—hypertension	0.00239	0.0092	CbGbCtD
Vandetanib—CYP3A4—Nisoldipine—hypertension	0.00239	0.0092	CbGbCtD
Vandetanib—CYP3A4—Eplerenone—hypertension	0.00231	0.00888	CbGbCtD
Vandetanib—CYP3A4—Diltiazem—hypertension	0.00231	0.00888	CbGbCtD
Vandetanib—CYP3A4—Enalapril—hypertension	0.00206	0.00792	CbGbCtD
Vandetanib—CYP3A4—Irbesartan—hypertension	0.00189	0.00724	CbGbCtD
Vandetanib—CYP3A4—Amlodipine—hypertension	0.00185	0.0071	CbGbCtD
Vandetanib—CYP3A4—Felodipine—hypertension	0.00178	0.00685	CbGbCtD
Vandetanib—CYP3A4—Nifedipine—hypertension	0.00172	0.00662	CbGbCtD
Vandetanib—CYP3A4—Nicardipine—hypertension	0.0017	0.00652	CbGbCtD
Vandetanib—CYP3A4—Carvedilol—hypertension	0.0017	0.00652	CbGbCtD
Vandetanib—CYP3A4—Propranolol—hypertension	0.00156	0.006	CbGbCtD
Vandetanib—CYP3A4—Clonidine—hypertension	0.00149	0.00573	CbGbCtD
Vandetanib—CYP3A4—Atorvastatin—hypertension	0.00133	0.0051	CbGbCtD
Vandetanib—CYP3A4—Losartan—hypertension	0.00121	0.00467	CbGbCtD
Vandetanib—CYP3A4—Verapamil—hypertension	0.00107	0.00412	CbGbCtD
Vandetanib—Bosutinib—BMPR2—hypertension	0.000649	0.194	CrCbGaD
Vandetanib—Bosutinib—PTK2—hypertension	0.00047	0.14	CrCbGaD
Vandetanib—Bosutinib—RPS6KB1—hypertension	0.000383	0.114	CrCbGaD
Vandetanib—VEGFA—Timolol—Penbutolol—hypertension	0.000349	0.133	CbGdCrCtD
Vandetanib—Afatinib—EGFR—hypertension	0.000307	0.0916	CrCbGaD
Vandetanib—RIPK2—heart—hypertension	0.000251	0.00367	CbGeAlD
Vandetanib—VEGFA—heart—hypertension	0.00025	0.00366	CbGeAlD
Vandetanib—VEGFA—smooth muscle tissue—hypertension	0.000248	0.00363	CbGeAlD
Vandetanib—Bosutinib—PDGFRB—hypertension	0.000247	0.0736	CrCbGaD
Vandetanib—EPHA8—central nervous system—hypertension	0.000246	0.0036	CbGeAlD
Vandetanib—FLT4—decidua—hypertension	0.000245	0.00359	CbGeAlD
Vandetanib—IRAK4—heart—hypertension	0.000245	0.00358	CbGeAlD
Vandetanib—RIPK2—decidua—hypertension	0.000244	0.00357	CbGeAlD
Vandetanib—VEGFA—decidua—hypertension	0.000243	0.00356	CbGeAlD
Vandetanib—ERBB3—heart—hypertension	0.00024	0.00351	CbGeAlD
Vandetanib—FYN—brainstem—hypertension	0.00024	0.00351	CbGeAlD
Vandetanib—BMPR1B—adrenal gland—hypertension	0.000238	0.00349	CbGeAlD
Vandetanib—IRAK4—decidua—hypertension	0.000238	0.00348	CbGeAlD
Vandetanib—FLT4—cardiovascular system—hypertension	0.000238	0.00348	CbGeAlD
Vandetanib—MAP2K5—myocardium—hypertension	0.000237	0.00347	CbGeAlD
Vandetanib—KDR—myocardium—hypertension	0.000237	0.00347	CbGeAlD
Vandetanib—RIPK2—cardiovascular system—hypertension	0.000236	0.00346	CbGeAlD
Vandetanib—MKNK1—adrenal cortex—hypertension	0.000233	0.00341	CbGeAlD
Vandetanib—STK35—cardiac atrium—hypertension	0.000232	0.0034	CbGeAlD
Vandetanib—FMO1—kidney—hypertension	0.000229	0.00336	CbGeAlD
Vandetanib—AXL—adrenal cortex—hypertension	0.000229	0.00335	CbGeAlD
Vandetanib—EPHA6—endocrine gland—hypertension	0.000228	0.00333	CbGeAlD
Vandetanib—FLT4—cortex of kidney—hypertension	0.000226	0.00331	CbGeAlD
Vandetanib—MKNK1—heart—hypertension	0.000225	0.00329	CbGeAlD
Vandetanib—PLK4—endocrine gland—hypertension	0.000225	0.00329	CbGeAlD
Vandetanib—VEGFA—cortex of kidney—hypertension	0.000225	0.00329	CbGeAlD
Vandetanib—SLK—nephron tubule—hypertension	0.000224	0.00328	CbGeAlD
Vandetanib—FMO1—cortex of kidney—hypertension	0.000223	0.00327	CbGeAlD
Vandetanib—FGR—heart—hypertension	0.000222	0.00325	CbGeAlD
Vandetanib—RET—heart—hypertension	0.000222	0.00325	CbGeAlD
Vandetanib—LCK—heart—hypertension	0.000222	0.00325	CbGeAlD
Vandetanib—FMO3—adrenal cortex—hypertension	0.000222	0.00325	CbGeAlD
Vandetanib—AXL—heart—hypertension	0.000221	0.00324	CbGeAlD
Vandetanib—ERBB3—kidney—hypertension	0.000221	0.00324	CbGeAlD
Vandetanib—SLK—adrenal cortex—hypertension	0.00022	0.00323	CbGeAlD
Vandetanib—AXL—smooth muscle tissue—hypertension	0.00022	0.00322	CbGeAlD
Vandetanib—CYP3A4—urine—hypertension	0.000219	0.0032	CbGeAlD
Vandetanib—MKNK1—decidua—hypertension	0.000219	0.0032	CbGeAlD
Vandetanib—PDGFRB—cardiac ventricle—hypertension	0.000218	0.00319	CbGeAlD
Vandetanib—FYN—nephron tubule—hypertension	0.000218	0.00319	CbGeAlD
Vandetanib—Erlotinib—EGFR—hypertension	0.000217	0.0647	CrCbGaD
Vandetanib—LCK—decidua—hypertension	0.000216	0.00316	CbGeAlD
Vandetanib—RET—decidua—hypertension	0.000216	0.00316	CbGeAlD
Vandetanib—FGR—decidua—hypertension	0.000216	0.00316	CbGeAlD
Vandetanib—AXL—decidua—hypertension	0.000215	0.00315	CbGeAlD
Vandetanib—FMO3—heart—hypertension	0.000215	0.00314	CbGeAlD
Vandetanib—RIPK2—cardiac atrium—hypertension	0.000214	0.00314	CbGeAlD
Vandetanib—VEGFA—cardiac atrium—hypertension	0.000214	0.00313	CbGeAlD
Vandetanib—SLK—heart—hypertension	0.000213	0.00312	CbGeAlD
Vandetanib—MKNK1—cardiovascular system—hypertension	0.000212	0.00311	CbGeAlD
Vandetanib—EPHA5—endocrine gland—hypertension	0.000211	0.00309	CbGeAlD
Vandetanib—TYRO3—endocrine gland—hypertension	0.000211	0.00309	CbGeAlD
Vandetanib—LYN—endocrine gland—hypertension	0.00021	0.00307	CbGeAlD
Vandetanib—FGR—cardiovascular system—hypertension	0.00021	0.00307	CbGeAlD
Vandetanib—TEK—adrenal cortex—hypertension	0.000209	0.00307	CbGeAlD
Vandetanib—AXL—cardiovascular system—hypertension	0.000209	0.00306	CbGeAlD
Vandetanib—SLK—decidua—hypertension	0.000207	0.00303	CbGeAlD
Vandetanib—FYN—heart—hypertension	0.000207	0.00303	CbGeAlD
Vandetanib—FLT3—adrenal gland—hypertension	0.000207	0.00303	CbGeAlD
Vandetanib—BMPR1B—endocrine gland—hypertension	0.000207	0.00303	CbGeAlD
Vandetanib—FYN—smooth muscle tissue—hypertension	0.000206	0.00301	CbGeAlD
Vandetanib—RET—kidney—hypertension	0.000205	0.003	CbGeAlD
Vandetanib—PDGFRB—myocardium—hypertension	0.000205	0.003	CbGeAlD
Vandetanib—EPHA6—central nervous system—hypertension	0.000205	0.003	CbGeAlD
Vandetanib—STK35—adrenal gland—hypertension	0.000203	0.00297	CbGeAlD
Vandetanib—TEK—heart—hypertension	0.000203	0.00296	CbGeAlD
Vandetanib—MAP4K5—heart—hypertension	0.000203	0.00296	CbGeAlD
Vandetanib—MKNK1—cortex of kidney—hypertension	0.000202	0.00296	CbGeAlD
Vandetanib—RIPK2—medulla oblongata—hypertension	0.000202	0.00296	CbGeAlD
Vandetanib—FYN—decidua—hypertension	0.000202	0.00295	CbGeAlD
Vandetanib—TEK—smooth muscle tissue—hypertension	0.000201	0.00294	CbGeAlD
Vandetanib—MAP4K5—smooth muscle tissue—hypertension	0.000201	0.00294	CbGeAlD
Vandetanib—AXL—cortex of kidney—hypertension	0.000199	0.00291	CbGeAlD
Vandetanib—Bosutinib—SRC—hypertension	0.000199	0.0593	CrCbGaD
Vandetanib—ABL2—adrenal gland—hypertension	0.000198	0.00289	CbGeAlD
Vandetanib—IRAK4—medulla oblongata—hypertension	0.000197	0.00289	CbGeAlD
Vandetanib—TEK—decidua—hypertension	0.000197	0.00288	CbGeAlD
Vandetanib—MAP4K5—decidua—hypertension	0.000197	0.00288	CbGeAlD
Vandetanib—YES1—nephron tubule—hypertension	0.000197	0.00288	CbGeAlD
Vandetanib—FYN—cardiovascular system—hypertension	0.000196	0.00286	CbGeAlD
Vandetanib—ABL1—cardiac ventricle—hypertension	0.000195	0.00285	CbGeAlD
Vandetanib—EPHB6—heart—hypertension	0.000194	0.00283	CbGeAlD
Vandetanib—YES1—adrenal cortex—hypertension	0.000193	0.00283	CbGeAlD
Vandetanib—EGFR—adrenal gland—hypertension	0.000193	0.00282	CbGeAlD
Vandetanib—MKNK1—cardiac atrium—hypertension	0.000193	0.00282	CbGeAlD
Vandetanib—SLK—cortex of kidney—hypertension	0.000192	0.00281	CbGeAlD
Vandetanib—MAP2K5—brainstem—hypertension	0.000191	0.0028	CbGeAlD
Vandetanib—FYN—kidney—hypertension	0.000191	0.0028	CbGeAlD
Vandetanib—TEK—cardiovascular system—hypertension	0.000191	0.0028	CbGeAlD
Vandetanib—EPHA5—central nervous system—hypertension	0.00019	0.00278	CbGeAlD
Vandetanib—TYRO3—central nervous system—hypertension	0.00019	0.00278	CbGeAlD
Vandetanib—AXL—cardiac atrium—hypertension	0.000189	0.00277	CbGeAlD
Vandetanib—LYN—central nervous system—hypertension	0.000189	0.00277	CbGeAlD
Vandetanib—EPHB6—decidua—hypertension	0.000188	0.00276	CbGeAlD
Vandetanib—FLT4—adrenal gland—hypertension	0.000188	0.00275	CbGeAlD
Vandetanib—YES1—heart—hypertension	0.000187	0.00274	CbGeAlD
Vandetanib—TEK—kidney—hypertension	0.000187	0.00274	CbGeAlD
Vandetanib—RIPK2—adrenal gland—hypertension	0.000187	0.00274	CbGeAlD
Vandetanib—VEGFA—adrenal gland—hypertension	0.000186	0.00273	CbGeAlD
Vandetanib—FYN—cortex of kidney—hypertension	0.000186	0.00273	CbGeAlD
Vandetanib—MAP3K19—central nervous system—hypertension	0.000186	0.00273	CbGeAlD
Vandetanib—BMPR1B—central nervous system—hypertension	0.000186	0.00273	CbGeAlD
Vandetanib—YES1—smooth muscle tissue—hypertension	0.000186	0.00272	CbGeAlD
Vandetanib—FMO1—adrenal gland—hypertension	0.000185	0.00271	CbGeAlD
Vandetanib—STK10—heart—hypertension	0.000185	0.00271	CbGeAlD
Vandetanib—Erlotinib—CYP3A5—hypertension	0.000183	0.0546	CrCbGaD
Vandetanib—ABL1—myocardium—hypertension	0.000183	0.00268	CbGeAlD
Vandetanib—IRAK4—adrenal gland—hypertension	0.000183	0.00267	CbGeAlD
Vandetanib—SLK—cardiac atrium—hypertension	0.000182	0.00267	CbGeAlD
Vandetanib—TEK—cortex of kidney—hypertension	0.000182	0.00267	CbGeAlD
Vandetanib—MAP4K5—cortex of kidney—hypertension	0.000182	0.00267	CbGeAlD
Vandetanib—YES1—decidua—hypertension	0.000182	0.00266	CbGeAlD
Vandetanib—MKNK1—medulla oblongata—hypertension	0.000182	0.00266	CbGeAlD
Vandetanib—STK10—decidua—hypertension	0.00018	0.00264	CbGeAlD
Vandetanib—SRC—heart—hypertension	0.00018	0.00263	CbGeAlD
Vandetanib—FLT3—endocrine gland—hypertension	0.000179	0.00263	CbGeAlD
Vandetanib—RET—medulla oblongata—hypertension	0.000179	0.00262	CbGeAlD
Vandetanib—AXL—medulla oblongata—hypertension	0.000179	0.00261	CbGeAlD
Vandetanib—SRC—smooth muscle tissue—hypertension	0.000179	0.00261	CbGeAlD
Vandetanib—FYN—cardiac atrium—hypertension	0.000177	0.00259	CbGeAlD
Vandetanib—STK35—endocrine gland—hypertension	0.000176	0.00257	CbGeAlD
Vandetanib—SRC—decidua—hypertension	0.000175	0.00256	CbGeAlD
Vandetanib—STK10—cardiovascular system—hypertension	0.000175	0.00256	CbGeAlD
Vandetanib—EPHB6—cortex of kidney—hypertension	0.000174	0.00255	CbGeAlD
Vandetanib—KDR—nephron tubule—hypertension	0.000174	0.00255	CbGeAlD
Vandetanib—MAP4K5—cardiac atrium—hypertension	0.000173	0.00254	CbGeAlD
Vandetanib—TEK—cardiac atrium—hypertension	0.000173	0.00254	CbGeAlD
Vandetanib—YES1—kidney—hypertension	0.000173	0.00253	CbGeAlD
Vandetanib—SLK—medulla oblongata—hypertension	0.000172	0.00252	CbGeAlD
Vandetanib—MAP2K5—adrenal cortex—hypertension	0.000171	0.00251	CbGeAlD
Vandetanib—KDR—adrenal cortex—hypertension	0.000171	0.00251	CbGeAlD
Vandetanib—STK10—kidney—hypertension	0.000171	0.0025	CbGeAlD
Vandetanib—SRC—cardiovascular system—hypertension	0.00017	0.00249	CbGeAlD
Vandetanib—YES1—cortex of kidney—hypertension	0.000168	0.00246	CbGeAlD
Vandetanib—MKNK1—adrenal gland—hypertension	0.000168	0.00246	CbGeAlD
Vandetanib—FYN—medulla oblongata—hypertension	0.000167	0.00245	CbGeAlD
Vandetanib—SRC—kidney—hypertension	0.000166	0.00243	CbGeAlD
Vandetanib—RET—adrenal gland—hypertension	0.000166	0.00243	CbGeAlD
Vandetanib—LCK—adrenal gland—hypertension	0.000166	0.00243	CbGeAlD
Vandetanib—FGR—adrenal gland—hypertension	0.000166	0.00243	CbGeAlD
Vandetanib—EPHB6—cardiac atrium—hypertension	0.000166	0.00242	CbGeAlD
Vandetanib—KDR—heart—hypertension	0.000166	0.00242	CbGeAlD
Vandetanib—MAP2K5—heart—hypertension	0.000166	0.00242	CbGeAlD
Vandetanib—AXL—adrenal gland—hypertension	0.000165	0.00242	CbGeAlD
Vandetanib—KDR—smooth muscle tissue—hypertension	0.000164	0.0024	CbGeAlD
Vandetanib—MAP4K5—medulla oblongata—hypertension	0.000163	0.00239	CbGeAlD
Vandetanib—TEK—medulla oblongata—hypertension	0.000163	0.00239	CbGeAlD
Vandetanib—FLT4—endocrine gland—hypertension	0.000163	0.00239	CbGeAlD
Vandetanib—VEGFA—Enalapril—Captopril—hypertension	0.000163	0.0621	CbGdCrCtD
Vandetanib—RIPK2—endocrine gland—hypertension	0.000162	0.00237	CbGeAlD
Vandetanib—MAP2K5—decidua—hypertension	0.000161	0.00236	CbGeAlD
Vandetanib—KDR—decidua—hypertension	0.000161	0.00236	CbGeAlD
Vandetanib—FMO1—endocrine gland—hypertension	0.000161	0.00235	CbGeAlD
Vandetanib—FMO3—adrenal gland—hypertension	0.00016	0.00235	CbGeAlD
Vandetanib—YES1—cardiac atrium—hypertension	0.00016	0.00234	CbGeAlD
Vandetanib—SLK—adrenal gland—hypertension	0.000159	0.00233	CbGeAlD
Vandetanib—STK35—central nervous system—hypertension	0.000158	0.00232	CbGeAlD
Vandetanib—MAP2K5—cardiovascular system—hypertension	0.000156	0.00229	CbGeAlD
Vandetanib—KDR—cardiovascular system—hypertension	0.000156	0.00229	CbGeAlD
Vandetanib—EPHB6—medulla oblongata—hypertension	0.000156	0.00228	CbGeAlD
Vandetanib—ERBB3—endocrine gland—hypertension	0.000155	0.00227	CbGeAlD
Vandetanib—FYN—adrenal gland—hypertension	0.000155	0.00226	CbGeAlD
Vandetanib—SRC—cardiac atrium—hypertension	0.000154	0.00225	CbGeAlD
Vandetanib—KDR—kidney—hypertension	0.000153	0.00224	CbGeAlD
Vandetanib—MAP4K5—adrenal gland—hypertension	0.000151	0.00221	CbGeAlD
Vandetanib—TEK—adrenal gland—hypertension	0.000151	0.00221	CbGeAlD
Vandetanib—YES1—medulla oblongata—hypertension	0.000151	0.00221	CbGeAlD
Vandetanib—MAP2K5—cortex of kidney—hypertension	0.000149	0.00218	CbGeAlD
Vandetanib—KDR—cortex of kidney—hypertension	0.000149	0.00218	CbGeAlD
Vandetanib—PDGFRB—adrenal cortex—hypertension	0.000148	0.00217	CbGeAlD
Vandetanib—ABL1—brainstem—hypertension	0.000148	0.00216	CbGeAlD
Vandetanib—MKNK1—endocrine gland—hypertension	0.000146	0.00213	CbGeAlD
Vandetanib—FMO1—central nervous system—hypertension	0.000145	0.00212	CbGeAlD
Vandetanib—EPHB6—adrenal gland—hypertension	0.000144	0.00211	CbGeAlD
Vandetanib—FGR—endocrine gland—hypertension	0.000144	0.00211	CbGeAlD
Vandetanib—RET—endocrine gland—hypertension	0.000144	0.00211	CbGeAlD
Vandetanib—AXL—endocrine gland—hypertension	0.000143	0.0021	CbGeAlD
Vandetanib—PDGFRB—heart—hypertension	0.000143	0.0021	CbGeAlD
Vandetanib—IRAK4—central nervous system—hypertension	0.000143	0.00209	CbGeAlD
Vandetanib—PDGFRB—smooth muscle tissue—hypertension	0.000142	0.00208	CbGeAlD
Vandetanib—MAP2K5—cardiac atrium—hypertension	0.000142	0.00207	CbGeAlD
Vandetanib—KDR—cardiac atrium—hypertension	0.000142	0.00207	CbGeAlD
Vandetanib—ERBB3—central nervous system—hypertension	0.00014	0.00205	CbGeAlD
Vandetanib—YES1—adrenal gland—hypertension	0.00014	0.00204	CbGeAlD
Vandetanib—ABCC1—myocardium—hypertension	0.000139	0.00204	CbGeAlD
Vandetanib—PDGFRB—decidua—hypertension	0.000139	0.00204	CbGeAlD
Vandetanib—FMO3—endocrine gland—hypertension	0.000139	0.00203	CbGeAlD
Vandetanib—STK10—adrenal gland—hypertension	0.000138	0.00202	CbGeAlD
Vandetanib—Gefitinib—EGFR—hypertension	0.000136	0.0405	CrCbGaD
Vandetanib—PDGFRB—cardiovascular system—hypertension	0.000135	0.00198	CbGeAlD
Vandetanib—SRC—adrenal gland—hypertension	0.000134	0.00197	CbGeAlD
Vandetanib—ABL1—nephron tubule—hypertension	0.000134	0.00196	CbGeAlD
Vandetanib—FYN—endocrine gland—hypertension	0.000134	0.00196	CbGeAlD
Vandetanib—Bosutinib—EGFR—hypertension	0.000134	0.0399	CrCbGaD
Vandetanib—MAP2K5—medulla oblongata—hypertension	0.000133	0.00195	CbGeAlD
Vandetanib—KDR—medulla oblongata—hypertension	0.000133	0.00195	CbGeAlD
Vandetanib—PDGFRB—kidney—hypertension	0.000132	0.00194	CbGeAlD
Vandetanib—ABL1—adrenal cortex—hypertension	0.000132	0.00193	CbGeAlD
Vandetanib—MKNK1—central nervous system—hypertension	0.000131	0.00192	CbGeAlD
Vandetanib—TEK—endocrine gland—hypertension	0.000131	0.00192	CbGeAlD
Vandetanib—MAP4K5—endocrine gland—hypertension	0.000131	0.00192	CbGeAlD
Vandetanib—RET—central nervous system—hypertension	0.00013	0.0019	CbGeAlD
Vandetanib—FGR—central nervous system—hypertension	0.00013	0.0019	CbGeAlD
Vandetanib—AXL—central nervous system—hypertension	0.000129	0.00189	CbGeAlD
Vandetanib—PDGFRB—cortex of kidney—hypertension	0.000129	0.00189	CbGeAlD
Vandetanib—ABL1—heart—hypertension	0.000128	0.00187	CbGeAlD
Vandetanib—ABL1—smooth muscle tissue—hypertension	0.000127	0.00185	CbGeAlD
Vandetanib—FMO3—central nervous system—hypertension	0.000125	0.00183	CbGeAlD
Vandetanib—MKNK1—Pindolol—Nadolol—hypertension	0.000125	0.0477	CbGdCrCtD
Vandetanib—ABL1—decidua—hypertension	0.000124	0.00182	CbGeAlD
Vandetanib—Erlotinib—CYP1A1—hypertension	0.000124	0.037	CrCbGaD
Vandetanib—MAP2K5—adrenal gland—hypertension	0.000124	0.00181	CbGeAlD
Vandetanib—KDR—adrenal gland—hypertension	0.000124	0.00181	CbGeAlD
Vandetanib—PDGFRB—cardiac atrium—hypertension	0.000123	0.00179	CbGeAlD
Vandetanib—YES1—endocrine gland—hypertension	0.000121	0.00177	CbGeAlD
Vandetanib—FYN—central nervous system—hypertension	0.000121	0.00177	CbGeAlD
Vandetanib—ABL1—cardiovascular system—hypertension	0.000121	0.00176	CbGeAlD
Vandetanib—STK10—endocrine gland—hypertension	0.00012	0.00176	CbGeAlD
Vandetanib—TEK—central nervous system—hypertension	0.000118	0.00173	CbGeAlD
Vandetanib—MAP4K5—central nervous system—hypertension	0.000118	0.00173	CbGeAlD
Vandetanib—ABL1—kidney—hypertension	0.000118	0.00173	CbGeAlD
Vandetanib—ALB—heart—hypertension	0.000118	0.00172	CbGeAlD
Vandetanib—SRC—endocrine gland—hypertension	0.000116	0.0017	CbGeAlD
Vandetanib—VEGFA—Enalapril—Fosinopril—hypertension	0.000116	0.0442	CbGdCrCtD
Vandetanib—PDGFRB—medulla oblongata—hypertension	0.000116	0.00169	CbGeAlD
Vandetanib—ABL1—cortex of kidney—hypertension	0.000115	0.00168	CbGeAlD
Vandetanib—Gefitinib—CYP3A5—hypertension	0.000115	0.0342	CrCbGaD
Vandetanib—EPHB6—central nervous system—hypertension	0.000113	0.00165	CbGeAlD
Vandetanib—MKNK1—Pindolol—Acebutolol—hypertension	0.00011	0.042	CbGdCrCtD
Vandetanib—ABL1—cardiac atrium—hypertension	0.000109	0.0016	CbGeAlD
Vandetanib—YES1—central nervous system—hypertension	0.000109	0.0016	CbGeAlD
Vandetanib—STK10—central nervous system—hypertension	0.000108	0.00158	CbGeAlD
Vandetanib—KDR—endocrine gland—hypertension	0.000107	0.00157	CbGeAlD
Vandetanib—MAP2K5—endocrine gland—hypertension	0.000107	0.00157	CbGeAlD
Vandetanib—PDGFRB—adrenal gland—hypertension	0.000107	0.00157	CbGeAlD
Vandetanib—SRC—central nervous system—hypertension	0.000105	0.00154	CbGeAlD
Vandetanib—ABL1—medulla oblongata—hypertension	0.000103	0.00151	CbGeAlD
Vandetanib—ABCC1—adrenal cortex—hypertension	0.000101	0.00147	CbGeAlD
Vandetanib—VEGFA—Enalapril—Moexipril—hypertension	0.000101	0.0383	CbGdCrCtD
Vandetanib—MKNK1—Pindolol—Metoprolol—hypertension	0.0001	0.0381	CbGdCrCtD
Vandetanib—ERBB3—Alprenolol—Acebutolol—hypertension	0.0001	0.0381	CbGdCrCtD
Vandetanib—ABCC1—heart—hypertension	9.73e-05	0.00142	CbGeAlD
Vandetanib—KDR—central nervous system—hypertension	9.66e-05	0.00141	CbGeAlD
Vandetanib—MAP2K5—central nervous system—hypertension	9.66e-05	0.00141	CbGeAlD
Vandetanib—ABL1—adrenal gland—hypertension	9.53e-05	0.0014	CbGeAlD
Vandetanib—MKNK1—Pindolol—Esmolol—hypertension	9.48e-05	0.0361	CbGdCrCtD
Vandetanib—ABCC1—decidua—hypertension	9.46e-05	0.00138	CbGeAlD
Vandetanib—PDGFRB—endocrine gland—hypertension	9.27e-05	0.00136	CbGeAlD
Vandetanib—ERBB3—Alprenolol—Metoprolol—hypertension	9.08e-05	0.0346	CbGdCrCtD
Vandetanib—ALB—adrenal gland—hypertension	8.8e-05	0.00129	CbGeAlD
Vandetanib—VEGFA—Enalapril—Perindopril—hypertension	8.79e-05	0.0335	CbGdCrCtD
Vandetanib—ABCC1—cortex of kidney—hypertension	8.75e-05	0.00128	CbGeAlD
Vandetanib—ORM1—endocrine gland—hypertension	8.7e-05	0.00127	CbGeAlD
Vandetanib—ERBB3—Alprenolol—Esmolol—hypertension	8.6e-05	0.0328	CbGdCrCtD
Vandetanib—ABCG2—nephron tubule—hypertension	8.46e-05	0.00124	CbGeAlD
Vandetanib—ERBB3—Alprenolol—Pindolol—hypertension	8.4e-05	0.032	CbGdCrCtD
Vandetanib—PDGFRB—central nervous system—hypertension	8.36e-05	0.00122	CbGeAlD
Vandetanib—MKNK1—Pindolol—Betaxolol—hypertension	8.35e-05	0.0318	CbGdCrCtD
Vandetanib—VEGFA—Enalapril—Quinapril—hypertension	8.33e-05	0.0318	CbGdCrCtD
Vandetanib—ABCG2—adrenal cortex—hypertension	8.33e-05	0.00122	CbGeAlD
Vandetanib—ABCC1—cardiac atrium—hypertension	8.32e-05	0.00122	CbGeAlD
Vandetanib—ABL1—endocrine gland—hypertension	8.27e-05	0.00121	CbGeAlD
Vandetanib—ERBB3—Alprenolol—Penbutolol—hypertension	8.21e-05	0.0313	CbGdCrCtD
Vandetanib—VEGFA—Enalapril—Benazepril—hypertension	8.13e-05	0.031	CbGdCrCtD
Vandetanib—ABCG2—heart—hypertension	8.05e-05	0.00118	CbGeAlD
Vandetanib—ORM1—central nervous system—hypertension	7.84e-05	0.00115	CbGeAlD
Vandetanib—ABCG2—decidua—hypertension	7.83e-05	0.00115	CbGeAlD
Vandetanib—Gefitinib—CYP1A1—hypertension	7.77e-05	0.0232	CrCbGaD
Vandetanib—ERBB3—Alprenolol—Betaxolol—hypertension	7.58e-05	0.0289	CbGdCrCtD
Vandetanib—ABL1—central nervous system—hypertension	7.45e-05	0.00109	CbGeAlD
Vandetanib—ABCC1—adrenal gland—hypertension	7.26e-05	0.00106	CbGeAlD
Vandetanib—VEGFA—Pindolol—Nadolol—hypertension	7.19e-05	0.0274	CbGdCrCtD
Vandetanib—Erlotinib—ALB—hypertension	6.91e-05	0.0206	CrCbGaD
Vandetanib—VEGFA—Enalapril—Trandolapril—hypertension	6.86e-05	0.0262	CbGdCrCtD
Vandetanib—ABCG2—medulla oblongata—hypertension	6.49e-05	0.00095	CbGeAlD
Vandetanib—VEGFA—Pindolol—Acebutolol—hypertension	6.33e-05	0.0241	CbGdCrCtD
Vandetanib—ABCG2—adrenal gland—hypertension	6.01e-05	0.00088	CbGeAlD
Vandetanib—VEGFA—Pindolol—Metoprolol—hypertension	5.75e-05	0.0219	CbGdCrCtD
Vandetanib—MKNK1—Pindolol—Propranolol—hypertension	5.67e-05	0.0216	CbGdCrCtD
Vandetanib—VEGFA—Pindolol—Esmolol—hypertension	5.45e-05	0.0208	CbGdCrCtD
Vandetanib—VEGFA—Enalapril—Lisinopril—hypertension	5.37e-05	0.0205	CbGdCrCtD
Vandetanib—VEGFA—Enalapril—Ramipril—hypertension	5.2e-05	0.0198	CbGdCrCtD
Vandetanib—CYP3A4—kidney—hypertension	5.18e-05	0.000758	CbGeAlD
Vandetanib—ERBB3—Alprenolol—Propranolol—hypertension	5.14e-05	0.0196	CbGdCrCtD
Vandetanib—VEGFA—Pindolol—Betaxolol—hypertension	4.79e-05	0.0183	CbGdCrCtD
Vandetanib—Gefitinib—ALB—hypertension	4.33e-05	0.0129	CrCbGaD
Vandetanib—CYP3A4—endocrine gland—hypertension	3.63e-05	0.000531	CbGeAlD
Vandetanib—CYP3A4—central nervous system—hypertension	3.27e-05	0.000479	CbGeAlD
Vandetanib—VEGFA—Pindolol—Propranolol—hypertension	3.25e-05	0.0124	CbGdCrCtD
Vandetanib—Pruritus—Olmesartan—hypertension	1.88e-05	0.000125	CcSEcCtD
Vandetanib—Vomiting—Doxazosin—hypertension	1.88e-05	0.000124	CcSEcCtD
Vandetanib—Decreased appetite—Losartan—hypertension	1.87e-05	0.000124	CcSEcCtD
Vandetanib—Gastrointestinal pain—Irbesartan—hypertension	1.87e-05	0.000124	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	1.87e-05	0.000124	CcSEcCtD
Vandetanib—Abdominal pain—Captopril—hypertension	1.87e-05	0.000124	CcSEcCtD
Vandetanib—Body temperature increased—Captopril—hypertension	1.87e-05	0.000124	CcSEcCtD
Vandetanib—Headache—Carvedilol—hypertension	1.87e-05	0.000124	CcSEcCtD
Vandetanib—Rash—Doxazosin—hypertension	1.86e-05	0.000123	CcSEcCtD
Vandetanib—Fatigue—Losartan—hypertension	1.86e-05	0.000123	CcSEcCtD
Vandetanib—Dermatitis—Doxazosin—hypertension	1.86e-05	0.000123	CcSEcCtD
Vandetanib—Gastrointestinal pain—Hydrochlorothiazide—hypertension	1.86e-05	0.000123	CcSEcCtD
Vandetanib—Vomiting—Fosinopril—hypertension	1.85e-05	0.000123	CcSEcCtD
Vandetanib—Nausea—Propranolol—hypertension	1.85e-05	0.000123	CcSEcCtD
Vandetanib—Oedema—Ramipril—hypertension	1.85e-05	0.000123	CcSEcCtD
Vandetanib—Headache—Doxazosin—hypertension	1.85e-05	0.000123	CcSEcCtD
Vandetanib—Dry mouth—Timolol—hypertension	1.84e-05	0.000122	CcSEcCtD
Vandetanib—Constipation—Losartan—hypertension	1.84e-05	0.000122	CcSEcCtD
Vandetanib—Pain—Losartan—hypertension	1.84e-05	0.000122	CcSEcCtD
Vandetanib—Vomiting—Eplerenone—hypertension	1.84e-05	0.000122	CcSEcCtD
Vandetanib—Rash—Fosinopril—hypertension	1.84e-05	0.000122	CcSEcCtD
Vandetanib—Dermatitis—Fosinopril—hypertension	1.84e-05	0.000122	CcSEcCtD
Vandetanib—Vomiting—Nifedipine—hypertension	1.83e-05	0.000121	CcSEcCtD
Vandetanib—Gastrointestinal pain—Furosemide—hypertension	1.83e-05	0.000121	CcSEcCtD
Vandetanib—Rash—Eplerenone—hypertension	1.83e-05	0.000121	CcSEcCtD
Vandetanib—Headache—Fosinopril—hypertension	1.83e-05	0.000121	CcSEcCtD
Vandetanib—Dermatitis—Eplerenone—hypertension	1.82e-05	0.000121	CcSEcCtD
Vandetanib—Diarrhoea—Valsartan—hypertension	1.82e-05	0.000121	CcSEcCtD
Vandetanib—Asthenia—Clonidine—hypertension	1.82e-05	0.000121	CcSEcCtD
Vandetanib—Vomiting—Verapamil—hypertension	1.82e-05	0.000121	CcSEcCtD
Vandetanib—Body temperature increased—Perindopril—hypertension	1.82e-05	0.000121	CcSEcCtD
Vandetanib—Abdominal pain—Perindopril—hypertension	1.82e-05	0.000121	CcSEcCtD
Vandetanib—Diarrhoea—Olmesartan—hypertension	1.82e-05	0.00012	CcSEcCtD
Vandetanib—Headache—Eplerenone—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Rash—Nifedipine—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Nervous system disorder—Ramipril—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Dermatitis—Nifedipine—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Body temperature increased—Irbesartan—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Abdominal pain—Irbesartan—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Thrombocytopenia—Ramipril—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Oedema—Timolol—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Loss of consciousness—Lisinopril—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Rash—Verapamil—hypertension	1.81e-05	0.00012	CcSEcCtD
Vandetanib—Dermatitis—Verapamil—hypertension	1.8e-05	0.00012	CcSEcCtD
Vandetanib—Headache—Nifedipine—hypertension	1.8e-05	0.00012	CcSEcCtD
Vandetanib—Pruritus—Clonidine—hypertension	1.8e-05	0.000119	CcSEcCtD
Vandetanib—Abdominal pain—Hydrochlorothiazide—hypertension	1.8e-05	0.000119	CcSEcCtD
Vandetanib—Body temperature increased—Hydrochlorothiazide—hypertension	1.8e-05	0.000119	CcSEcCtD
Vandetanib—Skin disorder—Ramipril—hypertension	1.8e-05	0.000119	CcSEcCtD
Vandetanib—Infection—Timolol—hypertension	1.8e-05	0.000119	CcSEcCtD
Vandetanib—Headache—Verapamil—hypertension	1.79e-05	0.000119	CcSEcCtD
Vandetanib—Cough—Lisinopril—hypertension	1.79e-05	0.000119	CcSEcCtD
Vandetanib—Nausea—Indapamide—hypertension	1.79e-05	0.000119	CcSEcCtD
Vandetanib—Nausea—Diltiazem—hypertension	1.79e-05	0.000119	CcSEcCtD
Vandetanib—Asthenia—Trandolapril—hypertension	1.78e-05	0.000118	CcSEcCtD
Vandetanib—Nervous system disorder—Timolol—hypertension	1.77e-05	0.000118	CcSEcCtD
Vandetanib—Nausea—Carvedilol—hypertension	1.77e-05	0.000118	CcSEcCtD
Vandetanib—Asthenia—Enalapril—hypertension	1.77e-05	0.000117	CcSEcCtD
Vandetanib—Body temperature increased—Furosemide—hypertension	1.77e-05	0.000117	CcSEcCtD
Vandetanib—Abdominal pain—Furosemide—hypertension	1.77e-05	0.000117	CcSEcCtD
Vandetanib—Gastrointestinal pain—Losartan—hypertension	1.76e-05	0.000117	CcSEcCtD
Vandetanib—Dizziness—Valsartan—hypertension	1.76e-05	0.000117	CcSEcCtD
Vandetanib—Skin disorder—Timolol—hypertension	1.76e-05	0.000116	CcSEcCtD
Vandetanib—Dizziness—Olmesartan—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Pruritus—Trandolapril—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Nausea—Doxazosin—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Chest pain—Lisinopril—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Arthralgia—Lisinopril—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Body temperature increased—Betaxolol—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Asthenia—Telmisartan—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Pruritus—Enalapril—hypertension	1.75e-05	0.000116	CcSEcCtD
Vandetanib—Anxiety—Lisinopril—hypertension	1.74e-05	0.000116	CcSEcCtD
Vandetanib—Diarrhoea—Clonidine—hypertension	1.74e-05	0.000115	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.74e-05	0.000115	CcSEcCtD
Vandetanib—Nausea—Fosinopril—hypertension	1.73e-05	0.000115	CcSEcCtD
Vandetanib—Pruritus—Telmisartan—hypertension	1.72e-05	0.000114	CcSEcCtD
Vandetanib—Nausea—Eplerenone—hypertension	1.72e-05	0.000114	CcSEcCtD
Vandetanib—Dry mouth—Lisinopril—hypertension	1.71e-05	0.000113	CcSEcCtD
Vandetanib—Nausea—Nifedipine—hypertension	1.71e-05	0.000113	CcSEcCtD
Vandetanib—Body temperature increased—Losartan—hypertension	1.7e-05	0.000113	CcSEcCtD
Vandetanib—Abdominal pain—Losartan—hypertension	1.7e-05	0.000113	CcSEcCtD
Vandetanib—Nausea—Verapamil—hypertension	1.7e-05	0.000113	CcSEcCtD
Vandetanib—Asthenia—Captopril—hypertension	1.7e-05	0.000113	CcSEcCtD
Vandetanib—Diarrhoea—Trandolapril—hypertension	1.7e-05	0.000112	CcSEcCtD
Vandetanib—Vomiting—Valsartan—hypertension	1.69e-05	0.000112	CcSEcCtD
Vandetanib—Diarrhoea—Enalapril—hypertension	1.69e-05	0.000112	CcSEcCtD
Vandetanib—Vomiting—Olmesartan—hypertension	1.69e-05	0.000112	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Ramipril—hypertension	1.68e-05	0.000112	CcSEcCtD
Vandetanib—Rash—Valsartan—hypertension	1.68e-05	0.000112	CcSEcCtD
Vandetanib—Dizziness—Clonidine—hypertension	1.68e-05	0.000111	CcSEcCtD
Vandetanib—Dermatitis—Valsartan—hypertension	1.68e-05	0.000111	CcSEcCtD
Vandetanib—Oedema—Lisinopril—hypertension	1.68e-05	0.000111	CcSEcCtD
Vandetanib—Pruritus—Captopril—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Rash—Olmesartan—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Insomnia—Ramipril—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Dermatitis—Olmesartan—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Headache—Valsartan—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Diarrhoea—Telmisartan—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Infection—Lisinopril—hypertension	1.67e-05	0.000111	CcSEcCtD
Vandetanib—Headache—Olmesartan—hypertension	1.66e-05	0.00011	CcSEcCtD
Vandetanib—Paraesthesia—Ramipril—hypertension	1.66e-05	0.00011	CcSEcCtD
Vandetanib—Asthenia—Perindopril—hypertension	1.65e-05	0.000109	CcSEcCtD
Vandetanib—Dyspnoea—Ramipril—hypertension	1.65e-05	0.000109	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Timolol—hypertension	1.65e-05	0.000109	CcSEcCtD
Vandetanib—Asthenia—Irbesartan—hypertension	1.64e-05	0.000109	CcSEcCtD
Vandetanib—Thrombocytopenia—Lisinopril—hypertension	1.64e-05	0.000109	CcSEcCtD
Vandetanib—Dizziness—Trandolapril—hypertension	1.64e-05	0.000109	CcSEcCtD
Vandetanib—Insomnia—Timolol—hypertension	1.63e-05	0.000108	CcSEcCtD
Vandetanib—Dizziness—Enalapril—hypertension	1.63e-05	0.000108	CcSEcCtD
Vandetanib—Asthenia—Hydrochlorothiazide—hypertension	1.63e-05	0.000108	CcSEcCtD
Vandetanib—Skin disorder—Lisinopril—hypertension	1.63e-05	0.000108	CcSEcCtD
Vandetanib—Dyspepsia—Ramipril—hypertension	1.63e-05	0.000108	CcSEcCtD
Vandetanib—Pruritus—Perindopril—hypertension	1.63e-05	0.000108	CcSEcCtD
Vandetanib—Paraesthesia—Timolol—hypertension	1.62e-05	0.000108	CcSEcCtD
Vandetanib—Pruritus—Irbesartan—hypertension	1.62e-05	0.000108	CcSEcCtD
Vandetanib—Diarrhoea—Captopril—hypertension	1.62e-05	0.000107	CcSEcCtD
Vandetanib—Vomiting—Clonidine—hypertension	1.62e-05	0.000107	CcSEcCtD
Vandetanib—Dyspnoea—Timolol—hypertension	1.61e-05	0.000107	CcSEcCtD
Vandetanib—Dizziness—Telmisartan—hypertension	1.61e-05	0.000107	CcSEcCtD
Vandetanib—Pruritus—Hydrochlorothiazide—hypertension	1.61e-05	0.000107	CcSEcCtD
Vandetanib—Decreased appetite—Ramipril—hypertension	1.61e-05	0.000107	CcSEcCtD
Vandetanib—Asthenia—Furosemide—hypertension	1.6e-05	0.000106	CcSEcCtD
Vandetanib—Rash—Clonidine—hypertension	1.6e-05	0.000106	CcSEcCtD
Vandetanib—Dermatitis—Clonidine—hypertension	1.6e-05	0.000106	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Ramipril—hypertension	1.6e-05	0.000106	CcSEcCtD
Vandetanib—Fatigue—Ramipril—hypertension	1.59e-05	0.000106	CcSEcCtD
Vandetanib—Headache—Clonidine—hypertension	1.59e-05	0.000106	CcSEcCtD
Vandetanib—Dyspepsia—Timolol—hypertension	1.59e-05	0.000106	CcSEcCtD
Vandetanib—Asthenia—Betaxolol—hypertension	1.59e-05	0.000105	CcSEcCtD
Vandetanib—Nausea—Valsartan—hypertension	1.58e-05	0.000105	CcSEcCtD
Vandetanib—Pruritus—Furosemide—hypertension	1.58e-05	0.000105	CcSEcCtD
Vandetanib—Constipation—Ramipril—hypertension	1.58e-05	0.000105	CcSEcCtD
Vandetanib—Nausea—Olmesartan—hypertension	1.58e-05	0.000105	CcSEcCtD
Vandetanib—Vomiting—Trandolapril—hypertension	1.58e-05	0.000105	CcSEcCtD
Vandetanib—Diarrhoea—Perindopril—hypertension	1.57e-05	0.000104	CcSEcCtD
Vandetanib—Decreased appetite—Timolol—hypertension	1.57e-05	0.000104	CcSEcCtD
Vandetanib—Vomiting—Enalapril—hypertension	1.57e-05	0.000104	CcSEcCtD
Vandetanib—Diarrhoea—Irbesartan—hypertension	1.57e-05	0.000104	CcSEcCtD
Vandetanib—Dizziness—Captopril—hypertension	1.57e-05	0.000104	CcSEcCtD
Vandetanib—Pruritus—Betaxolol—hypertension	1.57e-05	0.000104	CcSEcCtD
Vandetanib—Rash—Trandolapril—hypertension	1.56e-05	0.000104	CcSEcCtD
Vandetanib—Dermatitis—Trandolapril—hypertension	1.56e-05	0.000104	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Timolol—hypertension	1.56e-05	0.000104	CcSEcCtD
Vandetanib—Fatigue—Timolol—hypertension	1.56e-05	0.000103	CcSEcCtD
Vandetanib—Rash—Enalapril—hypertension	1.56e-05	0.000103	CcSEcCtD
Vandetanib—Dermatitis—Enalapril—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Diarrhoea—Hydrochlorothiazide—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Headache—Trandolapril—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Vomiting—Telmisartan—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Asthenia—Losartan—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Headache—Enalapril—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Pain—Timolol—hypertension	1.55e-05	0.000103	CcSEcCtD
Vandetanib—Rash—Telmisartan—hypertension	1.53e-05	0.000102	CcSEcCtD
Vandetanib—Dermatitis—Telmisartan—hypertension	1.53e-05	0.000102	CcSEcCtD
Vandetanib—Diarrhoea—Furosemide—hypertension	1.53e-05	0.000101	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Lisinopril—hypertension	1.53e-05	0.000101	CcSEcCtD
Vandetanib—Pruritus—Losartan—hypertension	1.53e-05	0.000101	CcSEcCtD
Vandetanib—Headache—Telmisartan—hypertension	1.53e-05	0.000101	CcSEcCtD
Vandetanib—Dizziness—Perindopril—hypertension	1.52e-05	0.000101	CcSEcCtD
Vandetanib—Insomnia—Lisinopril—hypertension	1.52e-05	0.000101	CcSEcCtD
Vandetanib—Dizziness—Irbesartan—hypertension	1.51e-05	0.000101	CcSEcCtD
Vandetanib—Diarrhoea—Betaxolol—hypertension	1.51e-05	0.0001	CcSEcCtD
Vandetanib—Gastrointestinal pain—Ramipril—hypertension	1.51e-05	0.0001	CcSEcCtD
Vandetanib—Nausea—Clonidine—hypertension	1.51e-05	0.0001	CcSEcCtD
Vandetanib—Paraesthesia—Lisinopril—hypertension	1.51e-05	9.99e-05	CcSEcCtD
Vandetanib—Vomiting—Captopril—hypertension	1.51e-05	9.99e-05	CcSEcCtD
Vandetanib—Dizziness—Hydrochlorothiazide—hypertension	1.5e-05	9.97e-05	CcSEcCtD
Vandetanib—Dyspnoea—Lisinopril—hypertension	1.49e-05	9.92e-05	CcSEcCtD
Vandetanib—Rash—Captopril—hypertension	1.49e-05	9.9e-05	CcSEcCtD
Vandetanib—Dermatitis—Captopril—hypertension	1.49e-05	9.89e-05	CcSEcCtD
Vandetanib—Headache—Captopril—hypertension	1.48e-05	9.84e-05	CcSEcCtD
Vandetanib—Gastrointestinal pain—Timolol—hypertension	1.48e-05	9.8e-05	CcSEcCtD
Vandetanib—Dizziness—Furosemide—hypertension	1.48e-05	9.8e-05	CcSEcCtD
Vandetanib—Dyspepsia—Lisinopril—hypertension	1.48e-05	9.79e-05	CcSEcCtD
Vandetanib—Diarrhoea—Losartan—hypertension	1.48e-05	9.79e-05	CcSEcCtD
Vandetanib—Nausea—Trandolapril—hypertension	1.47e-05	9.77e-05	CcSEcCtD
Vandetanib—Nausea—Enalapril—hypertension	1.47e-05	9.73e-05	CcSEcCtD
Vandetanib—Dizziness—Betaxolol—hypertension	1.46e-05	9.71e-05	CcSEcCtD
Vandetanib—Vomiting—Perindopril—hypertension	1.46e-05	9.7e-05	CcSEcCtD
Vandetanib—Abdominal pain—Ramipril—hypertension	1.46e-05	9.7e-05	CcSEcCtD
Vandetanib—Body temperature increased—Ramipril—hypertension	1.46e-05	9.7e-05	CcSEcCtD
Vandetanib—Decreased appetite—Lisinopril—hypertension	1.46e-05	9.67e-05	CcSEcCtD
Vandetanib—Vomiting—Irbesartan—hypertension	1.46e-05	9.66e-05	CcSEcCtD
Vandetanib—Rash—Perindopril—hypertension	1.45e-05	9.61e-05	CcSEcCtD
Vandetanib—Dermatitis—Perindopril—hypertension	1.45e-05	9.61e-05	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Lisinopril—hypertension	1.45e-05	9.6e-05	CcSEcCtD
Vandetanib—Nausea—Telmisartan—hypertension	1.45e-05	9.59e-05	CcSEcCtD
Vandetanib—Fatigue—Lisinopril—hypertension	1.45e-05	9.59e-05	CcSEcCtD
Vandetanib—Vomiting—Hydrochlorothiazide—hypertension	1.44e-05	9.58e-05	CcSEcCtD
Vandetanib—Rash—Irbesartan—hypertension	1.44e-05	9.58e-05	CcSEcCtD
Vandetanib—Dermatitis—Irbesartan—hypertension	1.44e-05	9.57e-05	CcSEcCtD
Vandetanib—Headache—Perindopril—hypertension	1.44e-05	9.55e-05	CcSEcCtD
Vandetanib—Headache—Irbesartan—hypertension	1.44e-05	9.52e-05	CcSEcCtD
Vandetanib—Pain—Lisinopril—hypertension	1.43e-05	9.51e-05	CcSEcCtD
Vandetanib—Constipation—Lisinopril—hypertension	1.43e-05	9.51e-05	CcSEcCtD
Vandetanib—Rash—Hydrochlorothiazide—hypertension	1.43e-05	9.5e-05	CcSEcCtD
Vandetanib—Dermatitis—Hydrochlorothiazide—hypertension	1.43e-05	9.5e-05	CcSEcCtD
Vandetanib—Abdominal pain—Timolol—hypertension	1.43e-05	9.48e-05	CcSEcCtD
Vandetanib—Body temperature increased—Timolol—hypertension	1.43e-05	9.48e-05	CcSEcCtD
Vandetanib—Dizziness—Losartan—hypertension	1.43e-05	9.46e-05	CcSEcCtD
Vandetanib—Headache—Hydrochlorothiazide—hypertension	1.42e-05	9.44e-05	CcSEcCtD
Vandetanib—Vomiting—Furosemide—hypertension	1.42e-05	9.43e-05	CcSEcCtD
Vandetanib—Rash—Furosemide—hypertension	1.41e-05	9.35e-05	CcSEcCtD
Vandetanib—Dermatitis—Furosemide—hypertension	1.41e-05	9.34e-05	CcSEcCtD
Vandetanib—Vomiting—Betaxolol—hypertension	1.41e-05	9.33e-05	CcSEcCtD
Vandetanib—Nausea—Captopril—hypertension	1.41e-05	9.33e-05	CcSEcCtD
Vandetanib—Headache—Furosemide—hypertension	1.4e-05	9.29e-05	CcSEcCtD
Vandetanib—Rash—Betaxolol—hypertension	1.39e-05	9.25e-05	CcSEcCtD
Vandetanib—Dermatitis—Betaxolol—hypertension	1.39e-05	9.25e-05	CcSEcCtD
Vandetanib—Headache—Betaxolol—hypertension	1.39e-05	9.19e-05	CcSEcCtD
Vandetanib—Gastrointestinal pain—Lisinopril—hypertension	1.37e-05	9.1e-05	CcSEcCtD
Vandetanib—Vomiting—Losartan—hypertension	1.37e-05	9.09e-05	CcSEcCtD
Vandetanib—Nausea—Perindopril—hypertension	1.37e-05	9.06e-05	CcSEcCtD
Vandetanib—Nausea—Irbesartan—hypertension	1.36e-05	9.03e-05	CcSEcCtD
Vandetanib—Rash—Losartan—hypertension	1.36e-05	9.02e-05	CcSEcCtD
Vandetanib—Dermatitis—Losartan—hypertension	1.36e-05	9.01e-05	CcSEcCtD
Vandetanib—Headache—Losartan—hypertension	1.35e-05	8.96e-05	CcSEcCtD
Vandetanib—Nausea—Hydrochlorothiazide—hypertension	1.35e-05	8.95e-05	CcSEcCtD
Vandetanib—Nausea—Furosemide—hypertension	1.33e-05	8.81e-05	CcSEcCtD
Vandetanib—Asthenia—Ramipril—hypertension	1.33e-05	8.8e-05	CcSEcCtD
Vandetanib—Abdominal pain—Lisinopril—hypertension	1.33e-05	8.79e-05	CcSEcCtD
Vandetanib—Body temperature increased—Lisinopril—hypertension	1.33e-05	8.79e-05	CcSEcCtD
Vandetanib—Nausea—Betaxolol—hypertension	1.31e-05	8.72e-05	CcSEcCtD
Vandetanib—Pruritus—Ramipril—hypertension	1.31e-05	8.68e-05	CcSEcCtD
Vandetanib—Asthenia—Timolol—hypertension	1.3e-05	8.6e-05	CcSEcCtD
Vandetanib—Nausea—Losartan—hypertension	1.28e-05	8.5e-05	CcSEcCtD
Vandetanib—Pruritus—Timolol—hypertension	1.28e-05	8.48e-05	CcSEcCtD
Vandetanib—Diarrhoea—Ramipril—hypertension	1.26e-05	8.39e-05	CcSEcCtD
Vandetanib—Diarrhoea—Timolol—hypertension	1.24e-05	8.2e-05	CcSEcCtD
Vandetanib—Dizziness—Ramipril—hypertension	1.22e-05	8.11e-05	CcSEcCtD
Vandetanib—Asthenia—Lisinopril—hypertension	1.2e-05	7.98e-05	CcSEcCtD
Vandetanib—Dizziness—Timolol—hypertension	1.2e-05	7.93e-05	CcSEcCtD
Vandetanib—Pruritus—Lisinopril—hypertension	1.19e-05	7.87e-05	CcSEcCtD
Vandetanib—Vomiting—Ramipril—hypertension	1.18e-05	7.8e-05	CcSEcCtD
Vandetanib—Rash—Ramipril—hypertension	1.17e-05	7.73e-05	CcSEcCtD
Vandetanib—Dermatitis—Ramipril—hypertension	1.16e-05	7.73e-05	CcSEcCtD
Vandetanib—Headache—Ramipril—hypertension	1.16e-05	7.68e-05	CcSEcCtD
Vandetanib—Vomiting—Timolol—hypertension	1.15e-05	7.62e-05	CcSEcCtD
Vandetanib—Diarrhoea—Lisinopril—hypertension	1.15e-05	7.61e-05	CcSEcCtD
Vandetanib—Rash—Timolol—hypertension	1.14e-05	7.56e-05	CcSEcCtD
Vandetanib—Dermatitis—Timolol—hypertension	1.14e-05	7.55e-05	CcSEcCtD
Vandetanib—Headache—Timolol—hypertension	1.13e-05	7.51e-05	CcSEcCtD
Vandetanib—Dizziness—Lisinopril—hypertension	1.11e-05	7.36e-05	CcSEcCtD
Vandetanib—Nausea—Ramipril—hypertension	1.1e-05	7.28e-05	CcSEcCtD
Vandetanib—Nausea—Timolol—hypertension	1.07e-05	7.12e-05	CcSEcCtD
Vandetanib—Vomiting—Lisinopril—hypertension	1.07e-05	7.07e-05	CcSEcCtD
Vandetanib—Rash—Lisinopril—hypertension	1.06e-05	7.01e-05	CcSEcCtD
Vandetanib—Dermatitis—Lisinopril—hypertension	1.06e-05	7.01e-05	CcSEcCtD
Vandetanib—Headache—Lisinopril—hypertension	1.05e-05	6.97e-05	CcSEcCtD
Vandetanib—Nausea—Lisinopril—hypertension	9.96e-06	6.61e-05	CcSEcCtD
Vandetanib—ALB—Metabolism—CD36—hypertension	4.09e-07	3.04e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—AKT1—hypertension	4.09e-07	3.04e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—MAPK8—hypertension	4.04e-07	3e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—hypertension	4.03e-07	3e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—EGFR—hypertension	4.01e-07	2.98e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—hypertension	4.01e-07	2.98e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—SRC—hypertension	3.99e-07	2.97e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—hypertension	3.98e-07	2.96e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TP53—hypertension	3.98e-07	2.96e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—FGF2—hypertension	3.98e-07	2.96e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTEN—hypertension	3.97e-07	2.95e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RHOA—hypertension	3.96e-07	2.95e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SERPINE1—hypertension	3.96e-07	2.94e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—MYC—hypertension	3.94e-07	2.93e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—EP300—hypertension	3.94e-07	2.93e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—hypertension	3.93e-07	2.92e-06	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—AKT1—hypertension	3.92e-07	2.92e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NOS3—hypertension	3.92e-07	2.92e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PIK3R1—hypertension	3.92e-07	2.92e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALDH2—hypertension	3.91e-07	2.91e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TP53—hypertension	3.88e-07	2.88e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MTHFR—hypertension	3.88e-07	2.88e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—EGFR—hypertension	3.85e-07	2.87e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—hypertension	3.84e-07	2.85e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TP53—hypertension	3.84e-07	2.85e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—FGF2—hypertension	3.83e-07	2.85e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CDKN1A—hypertension	3.82e-07	2.84e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RHOA—hypertension	3.82e-07	2.84e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—INS—hypertension	3.82e-07	2.84e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTEN—hypertension	3.81e-07	2.84e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HBA1—hypertension	3.81e-07	2.83e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPARA—hypertension	3.8e-07	2.83e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—EGFR—hypertension	3.79e-07	2.82e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—EP300—hypertension	3.79e-07	2.82e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP11A1—hypertension	3.78e-07	2.81e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PIK3R1—hypertension	3.78e-07	2.81e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NOS3—hypertension	3.78e-07	2.81e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—hypertension	3.78e-07	2.81e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CDKN1A—hypertension	3.77e-07	2.8e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PTEN—hypertension	3.76e-07	2.79e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—hypertension	3.76e-07	2.79e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTT1—hypertension	3.72e-07	2.76e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC9A1—hypertension	3.72e-07	2.76e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—MYC—hypertension	3.71e-07	2.76e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—hypertension	3.7e-07	2.75e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—hypertension	3.7e-07	2.75e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RELA—hypertension	3.69e-07	2.75e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IGF1—hypertension	3.69e-07	2.75e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AKT2—hypertension	3.69e-07	2.74e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CDKN1A—hypertension	3.69e-07	2.74e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—AGT—hypertension	3.68e-07	2.74e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PTEN—hypertension	3.68e-07	2.74e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MAPK8—hypertension	3.68e-07	2.73e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—AKT1—hypertension	3.67e-07	2.73e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GCLC—hypertension	3.67e-07	2.73e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CETP—hypertension	3.67e-07	2.73e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—hypertension	3.64e-07	2.71e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—hypertension	3.64e-07	2.71e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—EP300—hypertension	3.64e-07	2.7e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—hypertension	3.63e-07	2.7e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CDKN1A—hypertension	3.63e-07	2.7e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TP53—hypertension	3.63e-07	2.7e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PTEN—hypertension	3.62e-07	2.69e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MTOR—hypertension	3.62e-07	2.69e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CALM1—hypertension	3.62e-07	2.69e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOE—hypertension	3.61e-07	2.68e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MAPK8—hypertension	3.6e-07	2.68e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EP300—hypertension	3.58e-07	2.66e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—MYC—hypertension	3.58e-07	2.66e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CAV1—hypertension	3.57e-07	2.66e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—hypertension	3.57e-07	2.65e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—APOA1—hypertension	3.57e-07	2.65e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RELA—hypertension	3.56e-07	2.65e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—hypertension	3.55e-07	2.64e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—hypertension	3.55e-07	2.64e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MAPK8—hypertension	3.54e-07	2.63e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—hypertension	3.54e-07	2.63e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP17A1—hypertension	3.52e-07	2.62e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—hypertension	3.51e-07	2.61e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EP300—hypertension	3.51e-07	2.61e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SERPINE1—hypertension	3.51e-07	2.61e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—EGFR—hypertension	3.5e-07	2.6e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—hypertension	3.5e-07	2.6e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTEN—hypertension	3.49e-07	2.6e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MTOR—hypertension	3.49e-07	2.6e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TP53—hypertension	3.49e-07	2.59e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SRC—hypertension	3.48e-07	2.59e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS1—hypertension	3.48e-07	2.59e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ENO1—hypertension	3.48e-07	2.59e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—hypertension	3.48e-07	2.59e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EP300—hypertension	3.45e-07	2.57e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SRC—hypertension	3.41e-07	2.54e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—VEGFA—hypertension	3.39e-07	2.52e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—FGF2—hypertension	3.39e-07	2.52e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RHOA—hypertension	3.38e-07	2.51e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TP53—hypertension	3.37e-07	2.5e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—AKT1—hypertension	3.36e-07	2.5e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SRC—hypertension	3.36e-07	2.5e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—EGFR—hypertension	3.36e-07	2.5e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—hypertension	3.35e-07	2.49e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—hypertension	3.35e-07	2.49e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CTGF—hypertension	3.35e-07	2.49e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—AKT1—hypertension	3.35e-07	2.49e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PIK3R1—hypertension	3.35e-07	2.49e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NOS3—hypertension	3.35e-07	2.49e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—EP300—hypertension	3.33e-07	2.48e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—VEGFA—hypertension	3.32e-07	2.47e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GOT2—hypertension	3.32e-07	2.47e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HMGCR—hypertension	3.32e-07	2.47e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—hypertension	3.31e-07	2.46e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—AKT1—hypertension	3.28e-07	2.44e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—AKT1—hypertension	3.28e-07	2.44e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—VEGFA—hypertension	3.27e-07	2.43e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—AKT1—hypertension	3.26e-07	2.43e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADRA2A—hypertension	3.25e-07	2.42e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—AKT1—hypertension	3.24e-07	2.41e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—hypertension	3.23e-07	2.4e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—AKT1—hypertension	3.23e-07	2.4e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—hypertension	3.19e-07	2.37e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—MYC—hypertension	3.17e-07	2.36e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—hypertension	3.16e-07	2.35e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RELA—hypertension	3.15e-07	2.34e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—hypertension	3.15e-07	2.34e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPARG—hypertension	3.14e-07	2.34e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CDKN1A—hypertension	3.14e-07	2.33e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PTEN—hypertension	3.13e-07	2.33e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MYC—hypertension	3.12e-07	2.32e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—hypertension	3.12e-07	2.32e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—hypertension	3.1e-07	2.3e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—EGFR—hypertension	3.1e-07	2.3e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—AKT1—hypertension	3.09e-07	2.3e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MTOR—hypertension	3.09e-07	2.3e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—hypertension	3.08e-07	2.29e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—INS—hypertension	3.08e-07	2.29e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—AKT1—hypertension	3.06e-07	2.28e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MAPK8—hypertension	3.06e-07	2.28e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MYC—hypertension	3.06e-07	2.27e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EGFR—hypertension	3.05e-07	2.27e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—AKT1—hypertension	3.05e-07	2.27e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—hypertension	3.05e-07	2.27e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—TH—hypertension	3.04e-07	2.26e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—hypertension	3.03e-07	2.26e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CALM2—hypertension	3.03e-07	2.26e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—hypertension	3.02e-07	2.25e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CDKN1A—hypertension	3.02e-07	2.25e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PTEN—hypertension	3.02e-07	2.24e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MYC—hypertension	3.01e-07	2.24e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—hypertension	3e-07	2.23e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EGFR—hypertension	2.99e-07	2.22e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—EP300—hypertension	2.98e-07	2.22e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—AKT1—hypertension	2.98e-07	2.22e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—hypertension	2.97e-07	2.21e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—hypertension	2.96e-07	2.2e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC2A4—hypertension	2.96e-07	2.2e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GCG—hypertension	2.96e-07	2.2e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MAPK8—hypertension	2.95e-07	2.19e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EGFR—hypertension	2.94e-07	2.19e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—AKT1—hypertension	2.94e-07	2.19e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—hypertension	2.91e-07	2.17e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SRC—hypertension	2.9e-07	2.16e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EP300—hypertension	2.88e-07	2.14e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GOT1—hypertension	2.87e-07	2.13e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—AKT1—hypertension	2.84e-07	2.11e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VEGFA—hypertension	2.83e-07	2.1e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SRC—hypertension	2.8e-07	2.08e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—hypertension	2.79e-07	2.08e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—AKT1—hypertension	2.79e-07	2.07e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—STK11—hypertension	2.78e-07	2.07e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP19A1—hypertension	2.78e-07	2.07e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—AKT1—hypertension	2.73e-07	2.03e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VEGFA—hypertension	2.72e-07	2.03e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NOS3—hypertension	2.7e-07	2.01e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PIK3R1—hypertension	2.7e-07	2.01e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—hypertension	2.69e-07	2e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—AKT1—hypertension	2.69e-07	2e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—hypertension	2.69e-07	2e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CDKN1A—hypertension	2.68e-07	1.99e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTEN—hypertension	2.67e-07	1.99e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MAPK8—hypertension	2.61e-07	1.94e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MYC—hypertension	2.6e-07	1.93e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—hypertension	2.59e-07	1.93e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—COMT—hypertension	2.59e-07	1.92e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—hypertension	2.58e-07	1.92e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—AKT1—hypertension	2.58e-07	1.92e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TP53—hypertension	2.56e-07	1.91e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GNB3—hypertension	2.55e-07	1.9e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARGC1A—hypertension	2.55e-07	1.9e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EP300—hypertension	2.55e-07	1.89e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HMOX1—hypertension	2.54e-07	1.89e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TP53—hypertension	2.51e-07	1.87e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CAT—hypertension	2.51e-07	1.86e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MYC—hypertension	2.51e-07	1.86e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—hypertension	2.5e-07	1.86e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GNAS—hypertension	2.48e-07	1.85e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—AKT1—hypertension	2.48e-07	1.85e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—hypertension	2.47e-07	1.84e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TP53—hypertension	2.47e-07	1.84e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EGFR—hypertension	2.45e-07	1.82e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOB—hypertension	2.43e-07	1.81e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VEGFA—hypertension	2.41e-07	1.79e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—hypertension	2.38e-07	1.77e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—AKT1—hypertension	2.38e-07	1.77e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTM1—hypertension	2.37e-07	1.76e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—hypertension	2.35e-07	1.75e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—LPL—hypertension	2.32e-07	1.73e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—hypertension	2.3e-07	1.71e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—AKT1—hypertension	2.29e-07	1.7e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADCY5—hypertension	2.27e-07	1.69e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GPX1—hypertension	2.27e-07	1.69e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—hypertension	2.26e-07	1.68e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PRKCA—hypertension	2.24e-07	1.67e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP1A1—hypertension	2.24e-07	1.67e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MYC—hypertension	2.22e-07	1.65e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—hypertension	2.21e-07	1.65e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CD36—hypertension	2.21e-07	1.64e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—AKT1—hypertension	2.2e-07	1.63e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EGFR—hypertension	2.17e-07	1.61e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—AKT1—hypertension	2.17e-07	1.61e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTEN—hypertension	2.16e-07	1.6e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TP53—hypertension	2.14e-07	1.59e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—AKT1—hypertension	2.12e-07	1.58e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MTHFR—hypertension	2.09e-07	1.56e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—AKT1—hypertension	2.09e-07	1.55e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TP53—hypertension	2.06e-07	1.53e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—EP300—hypertension	2.06e-07	1.53e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARA—hypertension	2.05e-07	1.53e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—AKT1—hypertension	2.01e-07	1.5e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AGT—hypertension	1.99e-07	1.48e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—hypertension	1.95e-07	1.45e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CALM1—hypertension	1.95e-07	1.45e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOE—hypertension	1.95e-07	1.45e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CAV1—hypertension	1.93e-07	1.43e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—APOA1—hypertension	1.93e-07	1.43e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—hypertension	1.88e-07	1.4e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TP53—hypertension	1.82e-07	1.35e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—AKT1—hypertension	1.8e-07	1.34e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—AKT1—hypertension	1.74e-07	1.29e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPARG—hypertension	1.7e-07	1.26e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—hypertension	1.67e-07	1.24e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—hypertension	1.67e-07	1.24e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—INS—hypertension	1.66e-07	1.24e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—AKT1—hypertension	1.54e-07	1.14e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—hypertension	1.53e-07	1.13e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PIK3R1—hypertension	1.46e-07	1.09e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NOS3—hypertension	1.46e-07	1.09e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—hypertension	1.33e-07	9.92e-07	CbGpPWpGaD
Vandetanib—ALB—Metabolism—AKT1—hypertension	1.24e-07	9.24e-07	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTEN—hypertension	1.16e-07	8.65e-07	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—EP300—hypertension	1.11e-07	8.25e-07	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—AKT1—hypertension	6.71e-08	4.99e-07	CbGpPWpGaD
